Finzati - Logo
SPRO logo

Spero Therapeutics, Inc.

SPRO • Biotechnology
$1.21
▼ -0.01 (-0.82%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$71.80M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:28 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.21
Change-0.82%
Market Cap$71.80M
52W Range1.08 - 3.08
Beta1.48
Gross Margin100.00%
Oper. Margin-0.04%
Profit Margin14.38%
Debt/Eq0.05
Current Ratio7.59
Quick Ratio7.59
Volume1.28M

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
61/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59
Analyst view
No analyst data available now.

Company Overview

IPO: 11/2/2017
Industry: Biotechnology
P/B i: 2.21
Debt / Equity i: 0.05
Operating Margin: -0.04%
Net Margin: 14.38%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.05
Current Ratio: 7.59
Quick Ratio: 7.59
Status: Good

Insider Transactions

Recent executive and insider activity

Zack Debra
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/06/2026
Type
OTHER
Zack Debra
Transaction: 08/03/2026
BUY
Change
+162,311
Price
Not reported
Filing
08/06/2026
Type
BUY
Zack Debra
Transaction: 08/03/2026
BUY
Change
+324,675
Price
$1.54
Filing
08/06/2026
Type
BUY